Z-2591-2021 Class II Ongoing

Recalled by Elekta, Inc. — Sunnyvale, CA

FDA device recall Z-2591-2021 was initiated by Elekta, Inc. on Sep 2, 2021 and is designated Class II. Reason for recall: A drug strength in MOSAIQ can be changed during the ordering process and approved, but the saved drug strength reverts to the original value. The recall status is ongoing. Affected quantity: 31.

Recall details

Product Type
Devices
Report Date
Oct 6, 2021
Initiation Date
Sep 2, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31

Product description

MOSAIQ Oncology Information System

Reason for recall

A drug strength in MOSAIQ can be changed during the ordering process and approved, but the saved drug strength reverts to the original value.

Distribution pattern

Distribution was made to CA, CO, FL, ID, LA, MO, MS, NC, NH, NM, NV, NY, OH, OK, PA, SD, and WA. There was no military/government distribution. Foreign distribution was made to Australia, Canada, and the United Kingdom.

Code information

MOSAIQ 2.83 when run with First Data Bank (FDB), UDI/GTIN MOSAIQ 2.83 (0858164002367)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2591-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2591-2021. Report a data issue: hello@regdatalab.com.